Overview

A Study of LY3323795 in Healthy Participants

Status:
Completed
Trial end date:
2017-07-21
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the safety of LY3323795 and the effects it has on the body. The study drug or placebo (sugar pill) will be given by mouth to healthy participants. The study has three parts. Each participant may only enroll in one part. The study will last 14 to 43 days, depending on the part. Screening must be completed prior to study start.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Hydroxyitraconazole
Itraconazole